These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17286589)

  • 1. Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons.
    Lazzeri G; Lenzi P; Busceti CL; Ferrucci M; Falleni A; Bruno V; Paparelli A; Fornai F
    J Neurochem; 2007 Jun; 101(5):1414-27. PubMed ID: 17286589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities between methamphetamine toxicity and proteasome inhibition.
    Fornai F; Lenzi P; Gesi M; Ferrucci M; Lazzeri G; Capobianco L; de Blasi A; Battaglia G; Nicoletti F; Ruggieri S; Paparelli A
    Ann N Y Acad Sci; 2004 Oct; 1025():162-70. PubMed ID: 15542714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In PC12 cells neurotoxicity induced by methamphetamine is related to proteasome inhibition.
    Lazzeri G; Lenzi P; Gesi M; Ferrucci M; Fulceri F; Ruggieri S; Bruno V; Fornai F
    Ann N Y Acad Sci; 2006 Aug; 1074():174-7. PubMed ID: 17105915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamines induce ubiquitin-positive inclusions within striatal cells.
    Fornai F; Lazzeri G; Lenzi P; Gesi M; Ferrucci M; Soldani P; Pellegrini A; Capobianco L; De Blasi A; Ruggieri S; Paparelli A
    Neurol Sci; 2003 Oct; 24(3):182-3. PubMed ID: 14598077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.
    Fornai F; Lenzi P; Ferrucci M; Lazzeri G; di Poggio AB; Natale G; Busceti CL; Biagioni F; Giusiani M; Ruggieri S; Paparelli A
    Brain Res Bull; 2005 May; 65(5):405-13. PubMed ID: 15833595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity.
    Fornai F; Lazzeri G; Bandettini Di Poggio A; Soldani P; De Blasi A; Nicoletti F; Ruggieri S; Paparelli A
    Ann N Y Acad Sci; 2006 Aug; 1074():84-9. PubMed ID: 17105905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
    Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
    J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
    Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
    J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion.
    Fornai F; Alessandrì MG; Torracca MT; Bassi L; Scalori V; Corsini GU
    Ann N Y Acad Sci; 1998 May; 844():166-77. PubMed ID: 9668674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bupropion increases striatal vesicular monoamine transport.
    Rau KS; Birdsall E; Hanson JE; Johnson-Davis KL; Carroll FI; Wilkins DG; Gibb JW; Hanson GR; Fleckenstein AE
    Neuropharmacology; 2005 Nov; 49(6):820-30. PubMed ID: 16005476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
    Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells.
    Fornai F; Lenzi P; Gesi M; Soldani P; Ferrucci M; Lazzeri G; Capobianco L; Battaglia G; De Blasi A; Nicoletti F; Paparelli A
    J Neurochem; 2004 Jan; 88(1):114-23. PubMed ID: 14675155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New perspectives on the mechanism of methamphetamine-induced neurotoxicity].
    Kita T; Takeshima M; Wagner GC; Hozumi H; Miyazaki I; Asanuma M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Apr; 28(2):49-61. PubMed ID: 18516983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel molecule 'shati' increases dopamine uptake via the induction of tumor necrosis factor-alpha in pheochromocytoma-12 cells.
    Niwa M; Nitta A; Cen X; Kitaichi K; Ozaki N; Yamada K; Nabeshima T
    J Neurochem; 2008 Dec; 107(6):1697-708. PubMed ID: 19014384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-D in methamphetamine-induced apoptotic cell death.
    Kanthasamy A; Anantharam V; Ali SF; Kanthasamy AG
    Ann N Y Acad Sci; 2006 Aug; 1074():234-44. PubMed ID: 17105920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition.
    Fornai F; Lenzi P; Gesi M; Ferrucci M; Lazzeri G; Busceti CL; Ruffoli R; Soldani P; Ruggieri S; Alessandri MG; Paparelli A
    J Neurosci; 2003 Oct; 23(26):8955-66. PubMed ID: 14523098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explant cultures of dog substantia nigra and striatum: a model for the study of nigro-striatal dopamine neurons.
    Mytilineou C; Cohen G; Dembiec-Cohen D; Van Woert M; Hwang E
    J Neural Transm Suppl; 1983; 19():37-51. PubMed ID: 6321649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine manipulation alters immediate-early gene response of striatal parvalbumin interneurons to cortical stimulation.
    Trevitt JT; Morrow J; Marshall JF
    Brain Res; 2005 Feb; 1035(1):41-50. PubMed ID: 15713275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
    Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
    Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.